Rachel Bandli’s practice focuses on complex commercial and intellectual property litigation.  She has experience representing pharmaceutical companies in Hatch-Waxman patent infringement actions, as well as matters involving biosimilars.  She has also worked on multiple inter partes review (IPR) proceedings involving pharmaceutical products and medical devices.

Rachel has been recognized as a Rising Star by Super Lawyers.